The aging liver: Drug clearance and an oxygen diffusion barrier hypothesis

Clinical Pharmacokinetics

Volumn 34, Issue 5, 1998, Pages 359-373

  Le Couteur, David G ^a   McLean, Allan J ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CANBERRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CAFFEINE; CLOMETHIAZOLE; DIAZEPAM; DIGITOXIN; DILTIAZEM; FENTANYL; IBUPROFEN; IMIPRAMINE; INDOCYANINE GREEN; ISONIAZID; LIDOCAINE; LIVER ENZYME; MORPHINE; NAPROXEN; NIFEDIPINE; OXAZEPAM; PARACETAMOL; PETHIDINE; PHENAZONE; PHENYTOIN; PROPRANOLOL; PROTEIN; SALICYLIC ACID; TEMAZEPAM; THEOPHYLLINE; VALPROIC ACID; VERAPAMIL; WARFARIN;

AGING; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; DOSE CALCULATION; DRUG CLEARANCE; DRUG CONJUGATION; DRUG METABOLISM; DRUG PROTEIN BINDING; ELDERLY CARE; HUMAN; LIVER BLOOD FLOW; LIVER CELL; LIVER CLEARANCE; LIVER FUNCTION; LIVER WEIGHT; NONHUMAN; OXYGEN DIFFUSION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

EID: 0031898907     PISSN: 03125963     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003088-199834050-00003     Document Type: Review

References (101)

1. Offerhaus L. Drugs for the elderly. 2nd ed. Copenhagen: WHO Regional Publications, 1997
2. Le Couteur DG, Johnson AG. Drugs and the elderly: prescription idiosyncrasies. Mod Med 1997; 40: 30-7
3. Hurwitz N. Predisposing factors in adverse reactions to drugs. BMJ 1969; 1: 536-9
4. Lumley CE, Walker SR, Hall GC, et al. The under-reporting of adverse drug reactions seen in general practice. Pharm Med 1986; 1: 205-12
5. Hutchinson TA, Flegel KM, Kramer MS, et al. Frequency, severity and risk factors for adverse drug reactions in adult out-patients. J Chron Dis 1986; 39: 533-42
6. Monette J, Gurwitz JH, Avorn J. Epidemiology of adverse drug events in the nursing home setting. Drugs Aging 1995; 7: 203-11
7. Gurwitz JH, Avorn J. The ambiguous relation between aging and adverse drug reactions. Ann Intern Med 1991; 114: 956-67
8. Popper H. Aging and the liver. Prog Liver Dis 1986; VIII: 659-83
9. Vestal RE. Aging and determinants of hepatic drug clearance. Hepatology 1989; 9: 331-4
10. Kinirons MT, Crome P. Clinical pharmacokinetic considerations in the elderly: an update. Clin Pharmacokinet 1997; 33: 302-12
11. Schmucker DL, Aging and drug disposition: an update. Pharmacol Rev 1979; 30: 133-48
12. James OFW. Drugs and the ageing liver. J Hepatol 1985; 1: 431-5
13. Woodhouse K. Drugs and the liver. III: aging of the liver and the metabolism of drugs. Biopharm Drug Dispos 1992; 13: 311-20
14. Woodhouse KW, Mutch E, Williams FM. The effect of age on pathways of drug metabolism in human liver. Age Ageing 1984; 13: 328-34
15. Wynne HA, James OFW. The aging liver. Age Ageing 1990; 19: 1-3
16. Wilkinson GR. The effects of diet, aging and disease-states on presystemic elimination and oral drug bioavailability in humans. Adv Drug Deliv Rev 1997; 27: 129-59
17. Boyd E. Normal variability in weight of the adult human liver and spleen. Arch Pathol 1933; 16: 350-72
18. Calloway NO, Foley CF, Lagerbloom P. Uncertainties in geriatric data. II: organ size. J Am Geriatr Soc 1965; 13: 20-8
19. Tauchi H, Sato T. Hepatic cells of the aged. In: Kitani K, editor. Liver and aging. Amsterdam: Elsevier North Holland, 1978: 3-20
20. Bach B, Hansen JM, Kampmann JP, et al. Disposition of antipyrine and phenytoin correlated with age and liver volume in man. Clin Pharmacokinet 1981; 6: 389-96
21. Schnegg M, Lauterburg BH. Quantitative liver function in the elderly assessed by galactose elimination capacity, aminopyrine demethylation and caffeine clearance. J Hepatol 1986; 3: 164-71
22. Wynne HA, Cope LH, James OFW, et al. The effect of age and frailly upon acetanilide clearance in man. Age Ageing 1989; 18: 415-8
23. Wynne HA, Cope LH, Mutch E, et al. The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology 1989; 9: 297-301
24. Varga F, Fischer E. Age dependent changes in blood supply of the liver and in the biliary excretion of eosine in rats. In: Kitani K, editor. Liver and aging. Amsterdam: Elsevier North Holland, 1978: 327-42
25. Wiener L, Rabinovici N. Liver haemodynamics and age. Proc Soc Exp Biol Med 1961; 108: 752-4
26. Montgomery PR, Sitar DS. Hepatic uplake of indocyanine green and perfusion rale in rats: effects of age and albumin concentration. Can J Physiol Pharmacol 1988; 66: 592-5
27. Le Couleur DG, Rivory LP, Yi C, et al. Aging, acute oxidative injury and hepatocellular glucose transport in the rat. Int Hepatol Commun 1995; 3: 244-53
28. Martin G, Sewell B, Yeomans ND, et al. Ageing has no effect on the volume density of hepatocytes, reticulo-endothelial cells or the extracellular space in livers of female Sprague-Dawley rats. Clin Exp Pharmacol Physiol 1992; 19: 537-9
29. Schmucker DL. A quantitative morphological evaluation of hepatocytes in young mature and senescent fischer 344 male rats. In: Kitani K, editor. Liver and aging. Amsterdam: Elsevier North Holland, 1978: 21-38
30. Pieri C, Zs-Nagy I, Mazzufferri G, et al. The aging of rat liver as revealed by electron microscopic morphometry. I: basic parameters. Exp Gerontol 1975; 10: 291-304
31. Van Bezooijen CFA. Influence of age-related changes in rodent liver morphology and physiology on drug metabolism: a review. Mech Ageing Devel 1984; 25: 1-22
32. Sastre J, Pallardo FV, Pla R, et al. Aging of the liver: age-associated mitochondrial damage in intact hepatocytes. Hepatology 1996; 24: 1199-205
33. Sherlock S, Beam AG, Billing BH, et al. Splanchnic blood flow in man by the bromosulfthalein method: the relation of peripheral plasma bromosulfthalein level to calculated flow. J Lab Clin Med 1950; 35: 923-32
34. Zoli M, Iervese T, Abbati S, et al. Portal blood flow and velocity in aging man. Gerontology 1989; 35: 61-5
35. Wynne HA, Goudevenos J, Rawlins MD, et al. Hepatic drug clearance: the effect of age using indocyanine green as a model compound. Br J Clin Pharmacol 1990; 30: 634-7
36. Le Conteur DG, Rivory LP, Roberts MS, et al. Aging and the response of the isolated perfused rat liver to vasoactive drugs. Biochem Pharmacol 1992; 43: 913-5
37. Lautt WW, Greenway CV. Conceptual review of the hepatic vascular bed. Hepatology 1987; 7: 952-63
38. Handler JA, Genell CA, Goldstein RS. Hepatobiliary function in senescent male Sprague-Dawley rats. Hepatology 1994; 19: 1496-503
39. Finch CE. Enzyme activities, gene function and aging in mammals. Exp Gerontol 1972; 7: 53-67
40. Ward W, Richardson A. Effect of age on liver protein synthesis and degradation. Hepatology 1991; 5: 935-49
41. Greenblatt DJ. Reduced serum albumin concentration in the elderly: a report from the Boston Collaborative Drug Surveillance Program. J Am Geriatr Soc 1979; 27: 20-2
42. Campion EW, deLabry LO, Glynn RJ. The effect of age on serum albumin in healthy males: report from the Normative Aging Study. J Gerontol 1988; 43: M18-20
43. Chen JC, Ove P, Lansing AI. In vitro synthesis of microsomal protein and albumin in young and old rats. Biochim Biophys Acta 1977; 312: 598-607
44. Santa Maria C, Ayala A, Revilla E. Changes in superoxide dismutase activity in liver and lung of old rats. Free Radical Res 1996; 25: 401-5
45. Stio M, Iantomasi T, Favilli F, et al. Glutathione metabolism in heart and liver of the aging rat. Biochem Cell Biol 1994; 72: 58-61
46. Rikans LE. Influence of aging on the susceptibility of ruts to hepatoxic injury. Toxicol Appl Pharmacol 1984; 73: 243-9
47. Rikans LE. Age-related differences in the susceptibility to drug-induced hepatotoxicity. In: Kitani K, editor. Liver and aging. Amsterdam: Excerpta Medica, 1991: 59-71
48. Le Couleur DG, Rivory LP, Pond SM. The effects of aging and nutritional state on hypoxia-reoxygenation injury in the perfused rat liver. Transplantation 1994; 58: 531-6
49. Mooney H, Roberts R, Cooksley WGE, et al. Alterations in liver with aging. Clin Gastroenterol 1985; 14: 757-71
50. Kampmann JP, Sinding J, Moller-Jorgensen I. Effect of age on liver function. Geriatrics 1975; 30: 91-5
51. Gibson PR, Dudley FL. Ischemic hepatitis: clinical features, diagnosis, and prognosis. Aust NZ J Med 1984; 14: 822-5
52. Kato R, Vussanelli P, Frontino G. Variation in the activity of liver microsomal drug metabolising enzymes in rats in relation to age. Biochem Pharmacol 1964; 12: 1037-51
53. Iwamoto K, Watanabe J, Araki K, et al. Effect of age on the hepatic clearance of propranolol in rats. J Pharm Pharmacol 1985; 37: 466-70
54. Schmucker DL, Woodhouse KW, Wang RK, et al. Effects of age and gender on in vitro properties of human liver microsomal monooxygenases. Clin Pharmacol Ther 1990; 48: 365-74
55. Shimada T, Yamazaki H, Mimura M, et al. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 1994; 270: 414-23
56. Brodie MJ, Boobis AR, Bulpitt CJ, et al. Influence of liver disease and environmental factors on hepatic monooxygenase activity in vitro. Eur J Clin Pharmacol 1981; 20: 39-46
57. Hunt CM, Strater S, Slave GM. Effect of normal aging on the activity of human hepatic cytochrome P450IIE1. Biochem Pharmacol 1990; 40: 1666-9
58. Herd B, Wynne HA, Wright P, et al. The effect of age on glucuronidation and sulphation of paracetamol by human liver fractions. Br J Clin Pharmacol 1991; 32: 768-70
59. Durnas C, Loi CM, Cusack BJ. Hepatic drug metabolism and aging. Clin Pharmacokinet 1990; 19: 359-89
60. Vestal RE, Wood AJJ, Branch RA, et al. Studies of drug disposition in the elderly using model compounds. In: Kitani K. editor. Liver and aging. Amsterdam: Elsevier North Holland, 1978: 343-57
61. Rowland M, Tozer TN. Clinical Pharmacokinetics: concepts and applications. Philadelphia: Lea & Fehiger, 1989
62. Angus PW, Mihaly GW, Morgan DJ, et al. Oxygen dependence of omeprazole clearance and suphone and suphide metabolite formation in the isolated perfused rat liver. J Pharmacol Ther 1989; 250: 1043-7
63. Angus PW, Mihaly GW, Morgan DJ, et al. Oxygen dependence of salbutamol elimination by the isolated perfused rat liver. Biochem Pharmacol 1989; 38: 1443-9
64. Angus PW, Morgan DJ, Smallwood RA. Hypoxia and hepatic drug metabolism: clinical implications. Aliment Pharmacol Ther 1990; 4: 213-25
65. McLean AJ, Morgan DJ. Clinical pharmacokinetics in patients with liver disease. Clin Pharmacokinet 1991; 21: 42-69
66. Morgan DJ, McLean AJ. Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease: an update. Clin Pharmacokinet 1995; 29: 1-22
67. Owens N, Fretwell M, Willey C, et al. Distinguishing between the fit and frail elderly, and optimising pharmacotherapy. Drugs Aging 1994; 4: 47-55
68. Iber FL, Murphy PA, Connor ES. Age-related changes in the gastrointestinal system: effects on drug therapy. Drugs Aging 1994; 5: 34-48
69. Kitani K. Hepatic drug metabolism in the elderly. Hepatology 1986; 6: 316-9
70. Sotaneimi EA, Arranto AJ, Pelkonen O, et al. Age and cytochrome P450-linked drug metabolism in humans: an analysis of 226 subjects with equal histopathological conditions. Clin Pharmacol Ther 1997; 61: 331-9
71. Verbeeck RK, Cardinal JA, Wallace SM. Effect of age and sex on the plasma binding of acidic and basic drugs. Eur J Clin Pharmacol 1984; 27: 91-7
72. Patterson M, Heazelwood R, Shithurst B, et al. Plasma protein binding of phenytoin in the aged: in vivo studies. Br J Clin Pharmacol 1982; 13: 423-5
73. Davis D, Grossman SH, Kitchell BB, et al. The effects of aging and smoking on the plasma protein binding of lignocaine and diazepam. Br J Clin Pharmacol 1985; 19: 261-5
74. Boudinot SG, Funderburg ED, Boudinot FD. Effects of age on the pharmacokinetics of piroxicam in rats. J Pharm Sci 1993; 82: 254-7
75. Andros E, Detmar-Hanna D, Suteparuk S, et al. The effect of aging on the pharmacokinetics and pharmacodynamics of prazosin. Eur J Clin Pharmacol 1996; 50: 41-6
76. Shepherd AM, Hewick DS, Moreland TA, et al. Age as a determinant of sensitivity to warfarin. Br J Clin Pharmacol 1977; 4: 315-20
77. Schwartz JB, Capili H, Daughterly J. Aging of women alters S-verapamil pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther 1994; 55: 509-17
78. Bernus I, Dickmson RG, Hooper WD, et al. Anticonvulsant therapy in aged patients: clinical pharmacokinetic considerations. Drugs Aging 1997; 10: 278-89
79. Wallace SM, Verbeeck RK. Plasma protein binding of drugs in the elderly. Clin Pharmacokinet 1987; 12: 41-72
80. Branch RA. Drugs as indicators of hepatic function. Hepatology 1982; 2: 97-105
81. Branch RA, Shand DG. Propranolol disposition in chronic liver disease: a physiological approach. Clin Pharmacokinet 1976; 1: 264-79
82. Greenblatt DJ, Divoll M, Abernethy DR, et al. Reduced clearance of triazolam in old age: relation to antipyrine oxidizing capacity. Br J Clin Pharmacol 1982; 15: 303-9
83. Varin F, Huet P-M. Hepatic microcirculation in the perfused cirrhotic rat liver. J Clin Invest 1985; 76: 1904-12
84. Hickey PL, McLean AJ, Angus PW, et al. Increased sensitivity of propranolol clearance to reduced oxygen delivery in the isolated perfused cirrhotic rat liver. Gastroenterology 1996; 111: 1039-48
85. Kassissia I, Rose CP, Goresky CA, et al. Flow-limited tracer oxygen distribution in the isolated perfused rat liver: effects of temperature and hematocrit. Hepatology 1992; 16: 763-75
86. Hickey PL, Angus PW, McLean AJ, et al. Oxygen supplementation restores theophylline clearance to normal in cirrhotic rats. Gastroenterology 1995; 108: 1504-9
87. Rose CP, Goresky CA. Limitation of tracer oxygen uptake in the canine coronary circulation. Circ Res 1985; 56: 57-71
88. Blanchard J, Sawers SJA. Comparative pharmacokinetics of caffeine in young and elderly men. J Pharm Biopharm 1983; 11: 109-29
89. Pirke KM, Sintermann R, Vogt HJ. Testosterone and testosterone precursors in the spermatic vein and in the testicular tissue of old men: reduced oxygen suppy may explain the relative increase of testicular progesterone and 17a-hydroxyprogesterone content and production in old age. Gerontology 1980; 26: 221-30
90. Le Couteur D. The physiology of the aging liver. Brisbane: The University of Queensland, 1994
91. Vaz M, Rajkumar C, Wong J, et al. Oxygen consumption in the heart, hepatomesenteric bed and brain in young and elderly human subjects and accompanying sympathetic nervous activity. Metabolism 1996; 45: 1487-92
92. De Leeuw AM, Brouwer A, Knook DL. Sinusoidal endothelial cells of the liver: fine structure and function in relation to age. J Electron Microsc Tech 1990; 14: 218-36
93. Guenard H, Marthan R. Pulmonary gas exchange in elderly subjects. Eur Resp J 1996; 9: 2573-7
94. Le Couteur DG, Rivory LP, Pond SM. Hepatic intracellular pH during the prereplicative period following partial hepatectomy. Am J Physiol 1993; 264: G767-73
95. McLean AJ, Le Couteur DG. The effect of age on the hepatocyte uptake of solutes [abstract]. Clin Pharmacol Ther 1998. In press
96. Zs-Nagy I. The role of membrane structure and function in cellular aging: a review. Mech Ageing Devel 1979; 9: 237-46
97. Nokubo M. Physical-chemical and biochemical differences in liver plasma membranes in aging F-344 rats. J Gerontol 1985; 40: 409-14
98. Zs-Nagy I, Geynes M, Lustik G, et al. Age-dependent decrease of cell membrane permeability of rat hepatocytes as revealed by in vivo Rb+-uptake and release. In: Kitani K, editor. Liver and aging. Amsterdam: Elsevier Biomedical Press, 1982: 215-28
99. Kitani K, Zsolnai-Nagy I, Kanai S, et al. Correlation between the biliary excretion of ouabain and the lateral mobility of hepatocyte plasma membrane proteins in the rat: the effects of age and spironolactone pretreatment. Hepatology 1988; 8: 125-31
100. Gentile S, Persico M, Orlando C, et al. Age-associated decline of hepatic handling of cholephilic anions in humans is reverted by S-adenosylmethionine (SAMe). Scand J Clin Lab Invest 1990; 50: 565-71
101. Hegner D. Age-dependence of molecular and functional changes in biological membrane properties. Mech Ageing Devel 1980; 14: 101-18